We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I didnt give you any advice I merely asked who you were before this new account which has popped up....
To your other point my average is way below 9p, your correct about a year ago however I bought a sizeable chunk at 9p however I had sold an equivalent amount of shares at 10p having bought most from between 1.3p -> 7p'ish. In that perioud I made a few grand on other shares too so was not a bad move all things considered. That was the one and only time I have actually traded Hemo, I am not sure what the total value was at the time ill take your word on it that it was 2mil.
Justhereforhemo....read through your posting history and it appears you spent £180,000 buying 2m shares at 9p...I guess I wont be taking your advice !
If the Sp was 20 pence;I would be"long gone"When/If the SP gets to 5 pence I'll be gone with a small profit:thanks to Vlad and his fundraising:I only "invested" for the Covid update:for which Vlad had the money for:Guess he spent it on Champers
Brewsky don't waste your time, Hemo truth, wild stab in the dark as to your previous ID.... swimming in oil?
@Hemotruth no, I am in profit, I feel very fortunate to have been able to buy in so low and I have every sympathy for all current shareholders who are currently sitting on a paper loss. I see significant upside for this company provided Dr Sandler keeps to his word and uses non dilutive finance in future. There is obvious risk in Pharma and most small companies will fail to reach commercial success, however this risk is calculated into the market value against the potential upside of success. Hemogenyx is trading significantly below where it should be and where it would be were it not for the destructive nature of the CLNs on both the share price and image of the company, both need repaired, something a positive news flow and time will deliver.
Brewsky, it looks like we have already invested on a spike...and including you I would guess.
@Pumpky I see you are just incapable to compartmentalise, you see the success of a company only in the value of its SP. I somewhat suspect if all else was equal with no difference in actions taken by Hemogenyx and the team this past year and the SP was currently 20p you would be posting about how fantastic a job Hemo are doing and how they are heading to the moon. Am I correct? With this mindset you should avoid Pharma as you will only ever see potential in shares that have already delivered and thus forever invest on a spike.
My apologies Sir marc was correct 2021 will be the INFLECTION POINT(a turning point) for Hemo,correct SP 70%down since Vlad boasted of 400% shareholder gains last year
@Hemotruth I believe you are being intentionally disingenuous, I clearly stated I care about the SP and I would wholeheartedly agree with comments about the failure to address the SP with effective PR if Pumpky had said that. What I will not let pass without comment is allegations that the Company and Sir Marc are lying in regulated RNS's or insinuations that the company has failed to deliver this year in terms of progress towards clinical trials.
It is possible to believe that Hemogenyx have made fantastic progress whilst still being disappointed in the SP.
Please do not put words in my mouth.
Brewsky, you may not care about daily movements...but I certainly care about the SP being down 80% year on year....but hey ho, you are happy vlad has a new office.
Actually it did jump to 3p for about 1 minute as soon as the RNS came out, then dropped back over the course of the day to 2.3p approximately
3p? I dont think so 2.32p more like
This was 3p the other week, why is it constantly such a dreadful performer? They got some kind of partnership and then this has dropped 40% in 2 weeks?
Agreed, daily movements aren’t worth looking at. Also you have to believe what’s in a RNS, of course.
However if this SP is still hovering around 2/2.5p in a years time, then I think it’s an issue. I don’t for one minute think it will though. Too much in the pipeline IMO for me and expect it to double or triple bag within a year. We will see
@Hemotruth irrelevant.
Pumpky basically called Sir Mark Feldman and Hemogenyx a liar stating "Best not to believe everything that is written in an RNS". This is regulated by the Financial Conduct Authority, you either believe what is published in RNS or you report them to the FCA.
I care about the SP, but I dont care about daily movements just as I believe Sir Mark does not care about daily fluctuations , he cares about Hemogenyx bringing treatments to the clinical stage, in this regard progress this year has been significant and transformational. If Pumpky wants to post that she is very unhappy with the Share Price and performance of the stock and the efforts of Hemogenyx to effectively address the PR deficit to deliver value to investors then I will wholeheartedly agree.
Share price and cost of development - Speaking of which if I were Hemo I would be filing an ODD application for the CAR-T program sooner rather than later which would waive some of the application fees -this can be agreed with FDA upfront (90 day turn around) before filing the IND and if approved would grant the following:
Potential Pediatric Research Equity Act (PREA) requirements exemption
Waiver of the marketing application user fee
Tax credits and research grants for qualified clinical testing expenses
FDA protocol assistance
IMO of course
Brewsky, let's be honest, all shareholders care about is the share price !
@pumpky what have you achieved in 2021? I would like to do a quick run down of Hemogenyx achievements:
CAR-T Master Translational Agreement with Penn
Presented at H.C. Wainwright Investment Conference
U.S. Approval and Issuance of CDX Antibody Patent
U.S. Approval of Monoclonal Antibody Patent
Secured a CDX Licence Agreement with Eli Lilly
Lease of New York Mink Building Custom Laboratory
Plus new staff and significant progress towards IND application for CAR-T with plans to significantly reduce costs by producing cells in house.
I think its clear some people have rose tinted glasses about this share, but likewise its clear you have green tinted glasses for this share, you cannot look beyond the share price. As a company the progress made in the past 10 months is staggering, we all hope this will be reflected in the share price soon. Contrary to your view point I believe it is best to believe what is written in an RNS and not what is posted on un-moderated and wild west boards like here.
Chairman said 2021 was the year for Hemo(Best not to believe everything that is written in an RNS)
Wat a lot of boiler room b.s........
I will be very surprised if you have to wait until January 23 to get a decent SP rise. I would expect a double bag from here by 2022, as a minimum. Hopefully much more.
Just my opinion
I will average down and wait. I think if I don't see the company making good progress by Jan 2023 I may reconsider. But the MCap right now is tiny, and I don't want to miss out on a potentially nice rise for the sake of what I have invested.
great full :-)
I thought that 3 years ago ?
Took close to a £100k loss on Hemo In the last year or so . But since 2-2.5p i have been growing my position and currently have 3.5x my last years holdings.
A true blessing.
If I was willing to pay 5-13p a share, best believe I’ll take as many at 2p as possible. Within reason of course
All the pieces of the puzzle are coming together. I just hope I get a chance to buy more.